SSI Strategy

The Executive Advisory Network

About The Network

The Executive Advisory Network brings together some of the most globally recognized and prestigious experts across the pharmaceutical and biotech landscapes. All are renowned for their contributions in developing and launching successful assets and companies.

Safety & Pharmacovigilance (PV)

This curated network includes known quantities for SSI collaboration as we have worked or partnered with each member. We requested their participation as we share a similar mentality in partnership and delivery philosophy along with a proven shared track record. Collectively, we hold a passion to help our client partners achieve corporate objectives and advance therapeutic value.

Conflict-free, Independent Advisory – Each of our experts maintain independent operator and board roles outside of their support of the SSI Ex Ad Network. Our team completes a conflict check and gains alignment prior to onboarding any of our experts.

Our Services

Single-event Advisory to Longstanding Support
These experts are available for key meetings, coaching roles, structured workshops, among other forms
of go-forward support. SSI can confirm the options associated with each expert prior to engagement.

Description: Reposition organizational and program plans to maximize therapeutic opportunities for the company including interim leadership to support transition

Approach: Review and positioning of organizational and program plan with the goal of realigning org/plans
to maximize potential shots on a goal

Go-to-market & Turnaround Support

Description: Reposition organizational and program plans to maximize therapeutic opportunities for the company including interim leadership to support transition

Approach: Review and positioning of organizational and program plan with the goal of realigning org/plans to maximize potential shots on a goal

USMAN 'Oz' AZAM

GREG FIORE

FRED GROSSMAN

YURI MARICICH

Portfolio Strategy & IND Path Forward

Description: Strategize on a development roadmap for a potential asset or platform and create alignment to fundraising inflection points.

Approach: Shape the narrative and fortifying the business and clinical strategy around a potential asset from research through product development.

OSCAR SEGURADO

USMAN 'Oz' AZAM

PEDRO HUERTAS

JAMES 'JIM' WOOLDRIDGE